Sri J Obulareddy

Sourced from institutional research profiles (UAMS TRI or ARA).

Associate Professor

UAMS

COM | Internal Med Hem-Onc

2 h-index 6 pubs 21 cited

Research Areas

Biomedical Subjects

Links

Lab Website Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Sri J Obulareddy's research focuses on the intersection of oncology and immunology, with a specific interest in hepatocellular carcinoma and its tumor microenvironment. Obulareddy has investigated multimodal reprogramming of the tumor microenvironment through MMR and dual checkpoint blockade in preclinical models. Their work also includes exploring the role of gut microbiota in managing non-alcoholic fatty liver disease and examining the stem cell origin of cancer with implications for drug development and immunotherapy. Obulareddy has also participated in clinical trials, including a Phase I study of pazopanib and ixabepilone in patients with solid tumors. Their publications also address diagnostic challenges in nephrology and infectious diseases in immunocompromised individuals.

Metrics

h-index: 2
Publications: 6
Citations: 21

Selected Publications

Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025)

Frontiers in Immunology 1 citation DOI OpenAlex
Disparities in Leukemia Incidence and Mortality By Sex and Race in the United States from 1999 to 2020: A Retrospective Longitudinal Cross-Sectional Study Using Joinpoint Regression and Negative Binomial Analysis (2024)

Blood DOI OpenAlex
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment (2024)

Annals of Medicine and Surgery 4 citations DOI OpenAlex
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care (2024)

Cancers 2 citations DOI OpenAlex
526P Burden and trends of tracheal, bronchus, and lung (TBL) cancer in Southeast Asia, East Asia, and Oceania from 1990-2019, and its projection of deaths to 2040: A benchmarking analysis (2023)

Annals of Oncology DOI OpenAlex
177P Burden of stomach cancer attributable to smoking in South Asia from 1990-2019, its projection of deaths to 2040: A benchmarking and comparative analysis (2023)

Annals of Oncology DOI OpenAlex
116P Burden and trends of colorectal cancer in high income Asia Pacific countries from 1990-2019 and its projections of deaths to 2040: A comparative analysis (2023)

Annals of Oncology 1 citation DOI OpenAlex
Aplastic Anemia Mimicking Myelofibrosis: A Diagnostic Dilemma (2023)

Cureus DOI OpenAlex
A Case of Herpes Simplex Virus Meningitis in an Immunocompromised Individual: Avoiding Common Diagnostic Pitfalls (2023)

Cureus 3 citations DOI OpenAlex

Grants & Funding

As listed on this researcher's institutional profile.

276883 S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted Topathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study SouthWest Oncology Group Principal Investigator
276250 Alliance A011801,COMPASSHER2 Trials:COMPASSHER2 Residual Disease, A Double-Blinded, Phase III Randomized Trial of T-DM1&Placebo Compared with T-DM1 and Tucatinib Alliance for Clinical Trials in Oncology Principal Investigator
276249 Alliance A012103, OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy Alliance for Clinical Trials in Oncology Principal Investigator